Abstract
It is currently believed that the development of a clinically relevant tumor needs new vessel formation provided by both angiogenesis (primary involving endothelial cells) and postnatal vasculogenesis (primary involving bone marrowderived cells). Clearly, it is important to identify factors that help to enhance the growth and “health” of tumors, as well as their further vascularization. The Insulin and Insulin-like Growth Factors (IGFs) systems play a key role in cellular metabolism, differentiation, proliferation, transformation and apoptosis, during normal and malignant growth. Moreover, these molecules seem essential in promoting tumor vascularization. Due to the complexity of these systems, the review has been focused on the role of insulin and IGFs signaling in the regulation of tumor angiogenesis and postnatal vasculogenesis. Since targeting on IGF for cancer therapy is rapidly becoming a clinical reality, a better understanding of IGFsmediated pathways has a relevant impact, providing new insights to help the design of newly developed drugs.
Keywords: Insulin, Insulin-like growth factors, BM-derived cells, Endothelial cells, Tumor angiogenesis
Current Medicinal Chemistry
Title: The Effects of Insulin and Insulin-Like Growth Factors on Tumor Vascularization: New Insights of Insulin-Like Growth Factor Family in Cancer
Volume: 16 Issue: 30
Author(s): S. Orciari, S. Di Nuzzo, R. Lazzarini, P. Caprari, A. Procopio and A. Catalano
Affiliation:
Keywords: Insulin, Insulin-like growth factors, BM-derived cells, Endothelial cells, Tumor angiogenesis
Abstract: It is currently believed that the development of a clinically relevant tumor needs new vessel formation provided by both angiogenesis (primary involving endothelial cells) and postnatal vasculogenesis (primary involving bone marrowderived cells). Clearly, it is important to identify factors that help to enhance the growth and “health” of tumors, as well as their further vascularization. The Insulin and Insulin-like Growth Factors (IGFs) systems play a key role in cellular metabolism, differentiation, proliferation, transformation and apoptosis, during normal and malignant growth. Moreover, these molecules seem essential in promoting tumor vascularization. Due to the complexity of these systems, the review has been focused on the role of insulin and IGFs signaling in the regulation of tumor angiogenesis and postnatal vasculogenesis. Since targeting on IGF for cancer therapy is rapidly becoming a clinical reality, a better understanding of IGFsmediated pathways has a relevant impact, providing new insights to help the design of newly developed drugs.
Export Options
About this article
Cite this article as:
Orciari S., Di Nuzzo S., Lazzarini R., Caprari P., Procopio A. and Catalano A., The Effects of Insulin and Insulin-Like Growth Factors on Tumor Vascularization: New Insights of Insulin-Like Growth Factor Family in Cancer, Current Medicinal Chemistry 2009; 16 (30) . https://dx.doi.org/10.2174/092986709789352268
DOI https://dx.doi.org/10.2174/092986709789352268 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Standardization of Epitopes for Human Chorionic Gonadotropin (hCG) Immunoassays
Current Medicinal Chemistry Cardiovascular Effects of EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibodies
Cardiovascular & Hematological Agents in Medicinal Chemistry Photodynamic Inactivation of Bacteria
Current Bioactive Compounds The Application of the RNA Interference Technologies for KRAS: Current Status, Future Perspective and Associated Challenges
Current Topics in Medicinal Chemistry Natural Antioxidants: Therapeutic Prospects for Cancer and Neurological Diseases
Mini-Reviews in Medicinal Chemistry Epidemiology, Clinical Presentation and Treatment of Mucosal Melanoma
Clinical Cancer Drugs The Role of Snail in EMT and Tumorigenesis
Current Cancer Drug Targets Recent Clinical Trials of mTOR-Targeted Cancer Therapies
Reviews on Recent Clinical Trials LRIGs: A Prognostically Significant Family with Emerging Therapeutic Competence against Cancers
Current Cancer Drug Targets Natural Products and their Analogues as Efficient Anticancer Drugs
Mini-Reviews in Medicinal Chemistry Angiogenesis New Targets for the Development of Anticancer Chemotherapies
Current Pharmaceutical Design Cardiovascular Effects of Hypoglycemic Agents in Diabetes Mellitus
Current Drug Safety Targeted Delivery of Anti-Inflammatory Agents to Tumors
Current Pharmaceutical Design Role of ZEB Family Members in Proliferation, Metastasis, and Chemoresistance of Prostate Cancer Cells: Revealing Signaling Networks
Current Cancer Drug Targets Analysis of the Salivary Microbiome in the Periodontal Disease Patients with Hypertension and Non-hypertension
Current Bioinformatics Meet Our Editorial Board Member
Current Cancer Therapy Reviews Prokinetic Agents and QT Prolongation: A Familiar Scene with New Actors
Current Drug Safety Cancer Therapeutics: Emerging Targets and Trends
Current Cancer Therapy Reviews Understanding the Molecular Properties and Metabolism of Top Prescribed Drugs
Current Topics in Medicinal Chemistry Voltage-Gated Ion Channels, New Targets in Anti-Cancer Research
Recent Patents on Anti-Cancer Drug Discovery